Found 5 matching trials
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
PHASE2This is a Phase II, open-label multicentre, randomised study to assess the ...
Location
Hospices Civils de Lyon
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
PHASE3The purpose of this trial is to assess the long-term safety and efficacy of...
Location
UCLA Department of Medicine Division of Endocrinology
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
PHASE2The purpose of the trial is to compare the effectiveness and safety of 2 tr...
Status
Active Not Recruiting
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
PHASE3The purpose of this study is to compare the effectiveness and safety of CAM...
Status
Active Not Recruiting
Location
Mayo Clinic Cancer Center (MCCC) - Phoenix
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
PHASE3The purpose of this trial is to assess the efficacy and safety of CAM2029 i...
Location
UCLA Department of Medicine Division of Endocrinology